XT
JSPR icon

XTX Topco’s Jasper Therapeutics JSPR Stock Holding History

XTX Topco’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Sell
33,406
-6,025
-15% -$4.51K ﹤0.01% 3977
2026
Q1 		$34.5K Buy
+39,431
New +$54.7K ﹤0.01% 3417
2025
Q3 		– Sell
-27,348
Closed -$152K – 2911
2025
Q2 		$152K Buy
+27,348
New +$135K 0.01% 1786
2023
Q3 		– Sell
-1,129
Closed -$15.5K – 1785
2023
Q2 		$15.5K Buy
+1,129
New +$16.8K ﹤0.01% 1329

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's JSPR Position: Q2 2026 in Review

XTX Topco reduced its Jasper Therapeutics (JSPR) stake by 15% in Q2 2026, selling an estimated $4.51K and leaving 33,406 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3977.

XTX Topco first reported a position in JSPR in Q2 2023 and has held it in 4 quarters since. The position peaked at $152K in Q2 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • XTX Topco held 33,406 shares of Jasper Therapeutics worth $14.1K as of Q2 2026.
  • XTX Topco sold 6,025 Jasper Therapeutics shares in Q2 2026, an estimated $4.51K.
  • Jasper Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3977 holding.
  • XTX Topco first reported a position in Jasper Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • XTX Topco's Jasper Therapeutics position peaked at $152K in Q2 2025.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.